Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases (Nature reviews. Drug discovery (2017) 16 12 (843-862))

Daniella M. Schwartz, Yuka Kanno, Alejandro Villarino, Michael Ward, Massimo Gadina, John J. O'Shea

Research output: Contribution to journalComment/debatepeer-review

105 Scopus citations

Abstract

This corrects the article DOI: 10.1038/nrd.2017.201.

Original languageEnglish (US)
Pages (from-to)78
Number of pages1
JournalNature reviews. Drug discovery
Volume17
Issue number1
DOIs
StatePublished - Dec 28 2017
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases (Nature reviews. Drug discovery (2017) 16 12 (843-862))'. Together they form a unique fingerprint.

Cite this